Does resistance to apoptosis affect clinical response to antitumor drugs?
Authors:
- 1 April 2001
- journal article
- editorial
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (2) , 129-131
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Genetic analysis of chemoresistance in primary murine lymphomasNature Medicine, 2000
- In vivo veritas: Bcl-2 and Bcl-XLmediate tumor cell resistance to chemotherapyDrug Resistance Updates, 2000
- Epigenetic Determinants of Resistance to Etoposide Regulation of Bcl-xL and Bax by Tumor Microenvironmental FactorsJNCI: Journal of the National Cancer Institute, 2000
- Tumor Cells Utilize Multiple Pathways to Down‐modulate Apoptosis: Lessons from a Mouse Model of Islet Cell CarcinogenesisAnnals of the New York Academy of Sciences, 1999
- Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouseOncogene, 1998
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Programmed cell death (apoptosis) and response to anti-cancer drugsAnti-Cancer Drugs, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Drug-target interactions: only the first step in the commitment to a programmed cell death?British Journal of Cancer, 1991